• TEOSYAL® should be injected into the mucosa to treat the lips, or the mid dermis to correct fine lines.

• TEOSYAL® is ideal for patients seeking a natural-looking lip refreshment.
• Indicated to add volume to the lips and/or enhance their contour.
• Restore lost volume.
• Reshape lip contour using a small amount of gel.

Teosyal® RHA-Kiss comes in five variations, all hyaluronic acid dermal fillers designed to address fine lines and enhance lip volume. The primary function of RHA-Kiss is lip augmentation, adding volume and refining lip contours for a natural aesthetic. It can also treat perioral lines, the fine lines around the mouth. Key properties include:

• Unique formulation with smaller volume (0.7ml) for subtle enhancements and a natural look.
• High stretch and medium strength, ideal for lip reshaping with minimal product.
• Results in defined lips with a dynamic appearance.
• Inclusion of lidocaine for minimized discomfort during injection.

• RHA-KISS should be injected into the mucosa to treat the lips, or the mid dermis to correct fine lines.
• Injection into the middermis with a 30G needle.
• Average time to follow-up treatment: 9-18 months.
• Injection technique recommended by experts: Linear/tunnel technique.

Contraindications:

• Advise your doctor in case of known hypersensitivity to Hyaluronic Acid, with a history of severe allergy or anaphylactic shock.
• Contains 0.3% of lidocaine. Advise your doctor for guidance in case of:
  • Known hypersensitivity, allergy to lidocaine and/or local anesthetics of the amide type.
  • Athletes: lidocaine can induce a positive reaction to anti-doping tests.
  • Heart diseases and/or patient under treatment for heart disease (beta-blockers).
• Must not be used:
  • For injections other than intradermal.
  • In combination with peeling, laser or ultrasound-based treatments.
  • If the patient has cutaneous disorders, inflammation or infection at or near the treatment site.
  • In the case of known hypersensitivity to hyaluronic acid, with a history of severe allergy or anaphylactic shock.
  • In the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents.
  • In the case of patients having a known hypersensitivity to one of the excipients of the supplemented phosphate buffer.
  • In the case of patients with autoimmune diseases.
  • In the case of patients with cardiac diseases and/or undergoing treatment for heart diseases (beta blockers).
  • In the case of patients with hepatocellular insufficiency and/or undergoing treatment for liver disease.
  • In pregnancy, breastfeeding mothers, or in children.

After-care:

• The patient is advised to gently massage the area daily for at least 72 hours with the POST PROCEDURE cream to prevent a lymphatic lump from forming.